Raleigh, North Carolina and
Chicago, Illinois
October 19, 2007
Syngenta
Biotechnology Inc. announced today that it has entered into
a research and commercial license agreement for
Chromatin's proprietary
gene stacking technology.
Chromatin has developed a novel approach to gene stacking, using
the plant's own DNA to deliver several genes on a
mini-chromosome. Under the agreement, Syngenta has obtained
non-exclusive rights to use Chromatin's gene stacking technology
for trait genes in corn and soybeans
"Growers need increasingly more sophisticated tools to meet the
demands on the agriculture market, and stacked traits along with
improved seed germplasm will be instrumental," said Roger
Kemble, Head of Syngenta Crop Genetics Research. "We will
evaluate this technology in combination with our own innovative
research programs and strong pipeline as part of our intense
commitment to speed delivery of products to market."
"Syngenta is a leading agribusiness company committed to
developing crops that meet multiple needs. Chromatin is pleased
to partner with Syngenta, whose trait gene inventory and crop
production programs make them an ideal partner for us," said
Daphne Preuss, Chromatin's Chief Scientific Officer and
President.
Further terms of the deal were not disclosed.
Chromatin, Inc. develops and markets novel proprietary
technology that enables entire chromosomes to be designed and
incorporated into plant cells. These mini-chromosomes can be
used in any plant to simultaneously introduce multiple genes
while maintaining precise control of gene expression.
Chromatin’s mini-chromosome technology can be used to deliver
genes that benefit the agricultural, nutritional, energy,
pharmaceutical, and chemical sectors.
Syngenta is a world-leading
agribusiness committed to sustainable agriculture through
innovative research and technology. The company is a leader in
crop protection, and ranks third in the high-value commercial
seeds market. Sales in 2006 were approximately $8.1 billion.
Syngenta employs around 21,000 people in over 90 countries.
Syngenta is listed on the Swiss stock exchange (SYNN) and in New
York (NYSE: SYT).
Other news
from Chromatin,
Inc. |
|
